Accogli A et al. Sinus pericranii, skull defects, and structural brain anomalies in TRAF7-related disorder. Birth Defects Res. 2020;112(14):1085-1092. PMID: 32459067.
Bouwmeester T et al. A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol. 2004; 6(2):97-105. PMID: 14743216.
Castilla-Vallmanya L et al. Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7. Genet Med. 2020; 22(7):1215-1226; PMID: 32376980.
Chaisrisawadisuk S et al. Multi-suture craniosynostosis in c.1570C>T (p.Arg524Trp) mutated TRAF7: a case report. Childs Nerv Syst. 2021. PMID: 34247275.
Colleran JA et al. Novel mosaic TRAF7 likely pathogenic variant in an African American family. Am J Med Genet A. 2023;191(7):1990-1993. PMID: 37067385.
Scudiero I et al. Tumor necrosis factor (TNF) receptor-associated factor 7 is required for TNFalpha-induced Jun NH2-terminal kinase activation and promotes cell death by regulating polyubiquitination and lysosomal degradation of c-FLIP protein. J Biol Chem. 2012;287(8): 6053-6061. PMID: 22219201.
Tokita MJ et al. De Novo Missense Variants in TRAF7 Cause Developmental Delay, Congenital Anomalies, and Dysmorphic Features. Am J Hum Genet. 2018;103(1):154-162; PMID: 29961569.
Tsikitis M et al. Traf7, a MyoD1 transcriptional target, regulates nuclear factor-kappaB activity during myogenesis. EMBO Rep. 2010;11(12): 969-976. PMID: 20948544.
Xu D et al. Up-regulation of TNF Receptor-associated Factor 7 after spinal cord injury in rats may have implication for neuronal apoptosis. Neuropeptides. 2018; 71:81-89. PMID: 30100091.
Xu LG et al. TRAF7 potentiates MEKK3-induced AP1 and CHOP activation and induces apoptosis. J Biol Chem. 2004;279(17):17278-17282. PMID: 15001576.
Zotti T et al. The Emerging Role of TRAF7 in Tumor Development. J Cell Physiol. 2017;232(6):1233-1238. PMID: 27808423.
TRAF7